Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2023-08-10
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluid Responsiveness in Post Cardiac Surgery Patients
NCT06583200
Point Of Care Ultrasound For Prediction Of Fluid Responsiveness in Off Pump Coronary Artery Bypass Grafting Surgery
NCT05968040
Metabolic Fluid Responsiveness in Children
NCT07255469
How Much Cardiac Output is Enough?
NCT00619281
Superior Vena Cava Collapsibility Index for Predicting Fluid Responsiveness During High-risk Non-cardiac Surgery
NCT06188039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Furthermore, passive leg raising (PLR), end-expiratory occlusion test, and tidal volume challenge test, "Mini"-fluid challenge are currently available to assess fluid responsiveness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
occlusions test
Combined end expiratory (EEO) and inspiratory occlusion (EIO) test. A 15-s EEO separated by a time window of 1 minute to allow the hemodynamic parameters to return to baseline followed by a 15-s EIO
Combined end-expiratory occlusion and end-inspiratory occlusion test
The EEO test will be performed by interrupting the mechanical ventilation at end-expiration over 15 seconds using the end-expiratory hold button available on the ventilator.
The EIO test will be performed by interrupting the mechanical ventilation at end-inspiration over 15 seconds using the end-inspiratory hold button available on the ventilator.
challenge test
Tidal volume (TV) challenge test (transient increase of TV from 6 to 8 mL/kg for 1 minute)
Tidal volume challenge test
elevating tidal volume from 6 ml/kg to 8 ml/kg for only 60 seconds
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined end-expiratory occlusion and end-inspiratory occlusion test
The EEO test will be performed by interrupting the mechanical ventilation at end-expiration over 15 seconds using the end-expiratory hold button available on the ventilator.
The EIO test will be performed by interrupting the mechanical ventilation at end-inspiration over 15 seconds using the end-inspiratory hold button available on the ventilator.
Tidal volume challenge test
elevating tidal volume from 6 ml/kg to 8 ml/kg for only 60 seconds
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients ≥18 years of age
* patients undergoing cardiac surgery (coronary artery bypass graft, valve repair/ replacement, combined cardiac surgery)
* patients with normal systolic function of the left and right ventricle
* patient is mechanically ventilated with a protective lung strategy
Exclusion Criteria
* Patients undergoing emergent cardiac surgery.
* Patient with severe peripheral arterial occlusive disease
* Pregnant women
* Contraindication of passive leg raising test
* unstable post-operative course
* Post-operative complications such as uncontrolled bleeding, severe neurologic impairment, or accidental mechanical complications;
* presence of residual severe tricuspid or any valvular regurgitations
* low cardiac output, low ejection fractions (EF ≤45%)
* open chest,Pao2/Fio2 ≤ 200
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
tarek abdel hay mostafa
principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine, Tanta university
Tanta, El Gharbyia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
fluid responsiveness
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.